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Development of a second lymphoma after autotransplantation is an unusual event. Its real incidence, how-
In the present study, we report a patient with follicular lymphoma (centroblastic-centrocytic according to the Kiel ever, could be underestimated, since histologic and immunophenotyping techniques are often unable to disclassification) in apparent relapse with a Burkitt's lymphoma 42 months after autologous bone marrow transplantinguish it from a relapse. We report a lymphoma patient in apparent relapse after 42 months of molecutation (ABMT). VDJ sequencing of the relapse sample was performed because its PCR analysis with tumor-specific lar remission achieved by autotransplantation. Sequencing analysis of the immunoglobulin heavy-chain genes primers and probes from the diagnostic sample showed an apparent persistence of molecular remission, and because showed that the rearrangement of variable, diversity and joining segments had changed between diagnosis transformation of follicular lymphoma to Burkitt's lymphoma has been rarely reported. 6 Sequencing analysis of and relapse and suggested that a second lymphoma had developed.
the IgH genes showed that the VDJ rearrangement had changed between diagnosis and relapse and suggested that Keywords: non-Hodgkin lymphoma; autotransplantation; IgH genes; polymerase chain reaction; minimal residual a second lymphoma had developed after ABMT. disease
Case report
Although high-dose myeloablative therapy followed by A 41-year-old man was admitted for mediastinal and right reinfusion of bone marrow (BM) or peripheral blood (PB) inguinal lymph node enlargement. Complete blood cell cell harvests is a successful therapeutic strategy in B cell count was normal. Follicular NHL (centroblastic-centronon-Hodgkin lymphoma (NHL) and leads to complete cytic according to the Kiel classification) was diagnosed remission in 50-60% of cases, 1,2 relapse is still the leading from an inguinal node biopsy. Immunophenotype obtained cause of death. In contrast, the occurrence of a second lymon cell suspensions by flow cytometric analysis showed phoma arising from an unrelated neoplastic clone is CD19, CD20 and CD10 positivity, CD5 and CD23 negaunusual. Since NHL may progress from an indolent to a tivity and SIgM-clonal restriction. A BM biopsy was more aggressive histology during its natural history, histonegative. The patient achieved complete remission with the logic and immunophenotyping techniques are often unable MACOP-B protocol. 7 Chemotherapy was followed by to distinguish a second lymphoma from a relapse.
mediastinal radiotherapy (40 Gy). The patient remained Rearrangement of variable, diversity and joining (VDJ) well for 10 months before an aortic and right iliac lymph segments of the immunoglobulin heavy chain (IgH) genes node enlargement was observed. Histologic examination of generates unique DNA sequences specific to each B cell an inguinal node confirmed previous diagnosis. The BM clone. These sequences are called complementary determinbiopsy was still negative. ing regions (CDR) and code for the antigen binding site. 3 The patient was enrolled in a pilot study of high-dose In B cell malignancies, CDRs are utilized to design patientchemotherapy followed by PBPC and/or BM autografting.
2 specific primers and probes for amplification and hybridiz-A second complete remission was achieved. Abdominal ation procedures to detect minimal residual disease radiotherapy was delivered as consolidation treatment (MRD). 3, 4 Moreover, since VDJ rearrangement is a rela-(30 Gy). The patient remained well for 42 months. On the appearance of a 7 cm mass in the right iliac fossa, together with ascites and hyperuricemia, laparatomy showed diffuse examination of multiple biopsies revealed the presence of negatives, the DNA quality was tested by amplifying the sequence of P53 exon 5. Immunophenotype showed CD19, CD20 and CD10 positivity, CD5 and CD23 negativity and SIgM-clonal restriction. The BM biopsy was still negative. The patient Results and discussion responded poorly to two courses of doxorubicin, vincristine and prednisone. A more intensive regimen consisting of This study describes the VDJ analysis of patient with a high-dose Ara-C for 6 days significantly reduced the tumor follicular lymphoma in apparent relapse with a Burkitt's mass, but the aplasia it caused was complicated by mycotic lymphoma after 42 months of clinical and molecular pneumonia and fatal septic shock.
remission. The VDJ sequence was obtained from the diagnostic sample. Tumor-specific primers and probes were designed from the CDR regions for amplification and Materials and methods hybridization procedures. No tumor cells belonging to the diagnostic clone were detected in the relapse sample. This DNA extraction conflicted with the clinical observation of a massive relapse Lymph node and BM samples were collected at diagnosis, and prompted us to determine the VDJ rearrangement of after ABMT and at relapse. BM cells were separated on the relapse sample. Direct sequencing showed that it was a Ficoll-Hypaque density gradient. DNA was obtained by completely different from the diagnostic VDJ. Analysis of proteinase K digestion, phenol/chloroform extraction and the JH4 sequences at diagnosis and after relapse revealed ethanol precipitation. 8 two important facts: first, both the JH4 were different from the germline JH4; secondly, the pattern of somatic mutations of the two sequences was different (Figure 1) .
PCR amplification and sequencing
Since both sequences employed the JH4, clonal evolution Amplifications were performed as previously described. 4 could be supposed. Nevertheless, several studies in ALL Briefly, 1 g of DNA at diagnosis and at clinical relapse have shown that clonal evolution most commonly involves was amplified by using a family of IgH consensus sense modification of the VH-N region and leads, for example, primers derived from the first framework region and an to a VH → VH replacement, whereas the DJH junction antisense primer derived from the JH region. The reaction tends to remain relatively stable. 9 Furthermore, analysis of was carried out for 33 cycles (denaturation 94°for 30 s, two JH4 sequences with different patterns of somatic annealing 65°for 30 s and extension 72°for 30 s) with a mutation is evidence against clonal evolution. Our data thus final extension of 7 min. PCR products were analyzed by indicated that a second lymphoma had developed. electrophoresis on 2% LMP agarose gel. The expected band Secondary cancers are well-known late complications of was excised and phenol extracted. Direct sequencing reacconventional chemotherapy and BMT, with a reported incitions using the Promega (Madison, WI, USA) fmol sequendence of 1.3-to 20-fold for conventional treatments and cing system according to the manufacturer's instructions four-to seven-fold for BMT in comparison with the general were carried out in a thermocycler at 65°annealing tempopulation. 10 The etiology of second malignancy is multiperature for 15 cycles. Sequencing was analyzed with the factorial and may include irradiation, chemotherapy, PC-GENE software (IntelliGenetics, Mountain View, CA, immunosuppression in allogeneic BMT, viruses, and inter-USA).
action of any of these factors with genetic predisposition. While the risk of developing a second lymphoma is relatively high after allogeneic BMT, because of immune MRD detection deficiency, its occurrence after ABMT is unusual. Its effec-MRD analysis on diagnostic and relapse samples was pertive incidence, however, may be underestimated, since formed as follows: genomic DNA was amplified with a histologic and immunophenotyping techniques are unable CDR2-derived sense primer and a JH-derived antisense to distinguish a second lymphoma from a relapse. primer. The reaction was carried out for 33 cycles (denaturation 94°for 30 s, annealing 56°for 30 s, extension 72°for 30 s) with a final extension of 7 min. PCR products 
